Two Sigma Investments’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $771K | Sell |
19,025
-10,257
| -35% | -$416K | ﹤0.01% | 2334 |
|
2025
Q1 | $1.5M | Sell |
29,282
-61,889
| -68% | -$3.18M | ﹤0.01% | 1877 |
|
2024
Q4 | $5.05M | Sell |
91,171
-204,832
| -69% | -$11.3M | 0.01% | 1047 |
|
2024
Q3 | $9.74M | Sell |
296,003
-138,339
| -32% | -$4.55M | 0.02% | 733 |
|
2024
Q2 | $11.8M | Buy |
434,342
+286,516
| +194% | +$7.79M | 0.03% | 609 |
|
2024
Q1 | $5.37M | Buy |
147,826
+75,886
| +105% | +$2.76M | 0.01% | 891 |
|
2023
Q4 | $1.46M | Buy |
71,940
+17,842
| +33% | +$361K | ﹤0.01% | 1766 |
|
2023
Q3 | $961K | Buy |
54,098
+4,628
| +9% | +$82.2K | ﹤0.01% | 1892 |
|
2023
Q2 | $894K | Buy |
+49,470
| New | +$894K | ﹤0.01% | 1931 |
|
2022
Q4 | – | Sell |
-18,851
| Closed | -$323K | – | 3017 |
|
2022
Q3 | $323K | Sell |
18,851
-6,868
| -27% | -$118K | ﹤0.01% | 1894 |
|
2022
Q2 | $375K | Buy |
+25,719
| New | +$375K | ﹤0.01% | 1871 |
|